CSMD1 and hepatocellular carcinoma: Through survival analysis, CD5L was also shown to be favorable prognostic factor for overall survival and CSMD1 was shown to be unfavorable prognostic factor for disease-free survival in HCC patients (overall) (Fig. 9).